Ilaris: Lyophilisate for solution for injection (180mg)
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
What is this Medicine?
CANAKINUMAB is used to treat certain types of arthritis in children. It is also used to treat rare periodic fever syndromes including cryopyrin-associated periodic syndromes (CAPS), tumor necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome (HIDS)/mevalonate kinase deficiency (MKD), and familial Mediterranean fever (FMF). This medicine is not a cure.
ILARIS 180mg (150mg/mL) Powder for Injection
NDC: 000780582-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
Systemic Juvenile Idiopathic Arthritis, Cryopyrin-associated Periodic Syndromes (CAPS)
Store unreconstituted product in refrigerator (36 to 46 degrees F)
Protect from light
Store in original container
Do not freeze
Discard unused portion. Do not store for later use.
Reconstituted product should be refrigerated (36 to 46 degrees F) and used within 4 hours if not used immediately
Reported Side Effects for ILARIS 180mg (150mg/mL) Powder for Injection
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Be the first to share your experience!
We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.


